Synthesis and evaluation of chalcone analogues based pyrimidines as angiotensin converting enzyme inhibitors

20Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Hypertension is a widespread and frequently progressive ailment that imparts a foremost threat for cardiovascular and renal disorders. Mammoth efforts are needed for the synthesis of innovative antihypertensive agents to combat this lethal disease. Chalcones have shown antihypertensive activity through inhibition of Angiotensin Converting Enzyme (ACE). Hence, a series of chalcone analogues is synthesized and used as precursor for the synthesis of novel series of pyrimidines. Precursor chalcones were prepared by reacting aldehydes and ketones in presence of sodium hydroxide followed by synthesis of corresponding pyrimidines by reaction with urea in presence of potassium hydroxide. Both groups were then evaluated for their effects on ACE. The results depicted that pyrimidines were more active than chalcones with methoxy (C5 and P5) substitution showing best results to inhibit ACE. Given that chalcone analogues and pyrimidines show a potential as the angiotensin converting enzyme inhibitors. © 2013 Asian Network for Scientific Information.

Cite

CITATION STYLE

APA

Bukhari, S. N. A., Butt, A. M., Amjad, M. W. B., Ahmad, W., Shah, V. H., & Trivedi, A. R. (2013). Synthesis and evaluation of chalcone analogues based pyrimidines as angiotensin converting enzyme inhibitors. Pakistan Journal of Biological Sciences, 16(21), 1368–1372. https://doi.org/10.3923/pjbs.2013.1368.1372

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free